Abstract:Abstract Background Researching the murine epigenome in disease models has been hampered by the lack of an appropriate and cost-effective DNA methylation array. Until recently, investigators have been limited to the relatively expensive and analysis intensive bisulphite sequencing methods. Here, we performed a comprehensive, comparative analysis between the new Mouse Methylation BeadChip (MMB) and reduced representation bisulphite sequencing (RRBS) in two murine models of colorectal carcinogenesis, providing insight into the utility to each platforms in a real world environment. Results We captured 1.47×10 6 CpGs by RRBS and 2.64×10 5 CpGs by MMB, mapping to 13,778 and 13,365 CpG islands, respectively. RRBS captured significantly more CpGs per island (median 41 for RRBS versus 2 for MMB). We found that 64.4% of intra-island CpG methylation variability can be captured by measuring approximately one quarter of CpG island (CGI) CpGs. MMB was more precise in measuring DNA methylation, especially at sites that had low RRBS coverage. This impacted differential methylation analysis, with more statistically significantly differentially methylated CpG sites identified by MMB in all experimental conditions, however the difference was minute when appropriate thresholding for the magnitude of methylation change (0.2 beta value difference) was applied, providing confidence that both techniques can identify similar differential DNA methylation. Gene ontology enrichment analysis of differentially hypermethylated gene promoters identified similar biological processes and pathways by both RRBS and MMB across two murine model systems. Conclusion MMB is an effective tool for profiling the murine methylome that performs comparably to RRBS, identifying similar differentially methylated pathways. Although MMB captures a similar proportion of CpG islands, it does so with fewer CpGs per island. We show that subsampling informative CpGs from CpG islands is an appropriate strategy to capture whole island variation. Choice of technology is experiment dependent and will be predicated on the underlying biology being probed.

Characterisation and reproducibility of the HumanMethylationEPIC v2.0 BeadChip for DNA methylation profiling

Comprehensive evaluation of the Infinium human MethylationEPIC v2 BeadChip

Discrepancies in readouts between Infinium MethylationEPIC v2.0 and v1.0 reflected in DNA methylation-based tools: implications and considerations for human population epigenetic studies

Critical evaluation of the reliability of DNA methylation probes on the Illumina MethylationEPIC v1.0 BeadChip microarrays

Letter to the editor: critical evaluation of the reliability of DNA methylation probes on the illumina MethylationEPIC v1.0 BeadChip microarrays

ChAMP: updated methylation analysis pipeline for Illumina BeadChips

MethylCallR : a comprehensive analysis framework for Illumina Methylation Beadchip

Systematic investigation of interindividual variation of DNA methylation in human whole blood

mLiftOver: Harmonizing Data Across Infinium DNA Methylation Platforms

Technical and biological sources of unreliability of Infinium probes on Illumina methylation microarrays

A mammalian methylation array for profiling methylation levels at conserved sequences

MSA: scalable DNA methylation screening BeadChip for high-throughput trait association studies

A Framework for Analyzing DNA Methylation Data from Illumina Infinium HumanMethylation450 BeadChip

ImmuMethy, a database of DNA methylation plasticity at a single cytosine resolution in human blood and immune cells.

Comparative analysis of the Illumina Mouse Methylation BeadChip and Reduced Representation Bisulphite Sequencing for routine DNA methylation analysis of murine samples

RnBeads 2.0: comprehensive analysis of DNA methylation data

Comprehensive High-Throughput Arrays for Relative Methylation (Charm)

Validation of a DNA methylation microarray for 285,000 CpG sites in the mouse genome

The SEQC2 epigenomics quality control (EpiQC) study

DNA methylation-calling tools for Oxford Nanopore sequencing: a survey and human epigenome-wide evaluation